StockClub

ARQT

ARQTArcutis Biotherapeutics, Inc.$ --
Arcutis Biotherapeutics, Inc.

Arcutis Biotherapeutics, Inc.

ARQT

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
130M USD
YoY +81.5%
Operating Income
18M USD
YoY +340.9%
Net Income
17M USD
YoY +261.2%
EPS
0.14$
YoY +257.0%

Revenue

$376.1M
FY2024 Q1$49.6M
$49.6M
Q1
FY2024 Q2$80.4M
$80.4M
Q2
FY2024 Q3$125.2M
$125.2M
Q3
FY2024 Q4$196.5M
$196.5M
Q4
FY2025 Q1$65.8M
$65.8M
Q1
FY2025 Q2$147.3M
$147.3M
Q2
FY2025 Q3$246.6M
$246.6M
Q3
FY2025 Q4$376.1M
$376.1M
Q4
Actual
+$179.5M (+91.3%)

Net Income

$-16.1M
FY2024 Q1$-35.4M
$-35.4M
Q1
FY2024 Q2$-87.7M
$-87.7M
Q2
FY2024 Q3$-129.3M
$-129.3M
Q3
FY2024 Q4$-140M
$-140M
Q4
FY2025 Q1$-25.1M
$-25.1M
Q1
FY2025 Q2$-40.9M
$-40.9M
Q2
FY2025 Q3$-33.5M
$-33.5M
Q3
FY2025 Q4$-16.1M
$-16.1M
Q4
Actual
+$123.9M (+88.5%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020
Actual:$0
FY2020
$0
FY2021
Actual:$0
FY2021
$0
FY2022BEAT
Actual:$3.7M
Est:$3M
FY2022BEAT
$3.7M
FY2023MISS
Actual:$59.6M
Est:$132.1M
FY2023MISS
$59.6M
FY2024BEAT
Actual:$196.5M
Est:$185.5M
FY2024BEAT
$196.5M
FY2025BEAT
Actual:$376.1M
Est:$360.3M
FY2025BEAT
$376.1M

Analyst Estimates